Xuanping Zhang

Xuanping Zhang

Auto-generated profile, based on publicly available information

Xuanping Zhang

US Centers for Disease Control and Prevention, Atlanta, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in Diabetes Care
Verified
Journal Article
Open access
PDF file
XZXuanping Zhang
Xuanping Zhang
EGEdward W. Gregg
Edward W. Gregg
DWDavid F. Williamson
David F. Williamson
LBLawrence E. Barker
Lawrence E. Barker
WTWilliam Thomas
William Thomas
AAAnn L. Albright
Ann L. Albright
The use of A1C for the identification of persons with undiagnosed diabetes has been investigated for a number of years (1–3). A1C better reflects long-term glycemic exposure than current diagnostic tests based on point-in-time measures of fasting and postload blood glucose (4,5) and has improved test-retest reliability (6). In addition, A1C includes no requirement for fasting or for the oral glucose tolerance test's 2-h wait. These advantages should lead to increased identification and more timely treatment of persons with diabetes. Recently, an American Diabetes Association (ADA)-organized international expert committee recommended the adoption of the A1C assay for the diagnosis of diabetes at a cut point of 6.5% (7). This cut point was primarily derived from a review of studies that examined the association of A1C values with incident retinopathy, and some of the most influential data were obtained from recently published prospective studies. Retinopathy was chosen as the ultimate criterion because it is among the main complications of diabetes. Identification of the point on the A1C distribution most closely related to future retinopathy will identify persons in the greatest need of interventions for the prevention of diabetes complications. In addition to utility and convenience, A1C could help identify persons at increased risk of developing diabetes. This is an important public health priority since a structured lifestyle program or the drug metformin can reduce the incidence of diabetes by at least 50 and 30%, respectively (8). Ideally, selection of diagnostic cut points for pre-diabetes would be based on evidence that intervention, when applied to the high-risk group of interest, results not only in the prevention of diabetes but also later complications. However, currently there are no trials that can provide data to determine the ideal method for defining cut points. In the absence of such data, expert …

1 April 2005 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
XZXuanping Zhang
Xuanping Zhang
SNSusan L. Norris
Susan L. Norris
EGEdward W. Gregg
Edward W. Gregg
YCYiling J. Cheng
Yiling J. Cheng
GBGloria Beckles
Gloria Beckles
HKHenry S. Kahn
Henry S. Kahn
Although people with diabetes mellitus have a high risk of depression and depression may increase mortality among people with other conditions, the impact of depression on mortality risk among people with diabetes needs further examination. Using survival analysis, the authors analyzed longitudinal data from the NHANES I Epidemiologic Follow-up Study (1982–1992). The findings showed that the presence of severe depressive symptoms significantly elevated mortality risk among US adults with diabetes; the same pattern was not observed among people without diabetes. After results were controlled for sociodemographic, lifestyle, and health-status variables, diabetic persons with Centers for Epidemiologic Studies Depression (CES-D) Scale scores of 16 or more had 54% greater mortality than those with scores under 16 (p = 0.004). After exclusion of participants who died during the first year of follow-up, mortality remained higher among those with CES-D scores greater than or equal to 22 as compared with those with CES-D scores less than 16, but not among those with CES-D scores between 16 and 21. No significant relation between depression and mortality was found in the nondiabetic population. This analysis indicates that diabetes modifies the effect of depression on mortality. It also demonstrates the importance of observing subgroups, rather than aggregated populations, when examining the effect of depression on mortality.

12 June 2012 in Diabetes Care
Verified
Journal Article
Open access
PDF file
XZXuanping Zhang
Xuanping Zhang
KBKai McKeever Bullard
Kai McKeever Bullard
EGEdward W. Gregg
Edward W. Gregg
GBGloria L. Beckles
Gloria L. Beckles
DWDesmond E. Williams
Desmond E. Williams
GIGiuseppina Imperatore
Giuseppina Imperatore
OBJECTIVE: To examine the relationship between access to health care and diabetes control. RESEARCH DESIGN AND METHODS: Using data from the National Health and Nutrition Examination Survey, 1999–2008, we identified 1,221 U.S. adults (age 18–64 years) with self-reported diabetes. Access was measured by current health insurance coverage, number of times health care was received over the past year, and routine place to go for health care. Diabetes control measures included the proportion of people with A1C >9%, blood pressure ≥140/90 mmHg, and non-HDL cholesterol ≥130 mg/dL. RESULTS: An estimated 16.0% of known diabetic adults were uninsured. Diabetes control profiles were worse among uninsured than among insured persons (A1C >9% [34.1 vs. 16.5%, P = 0.002], blood pressure ≥140/90 mmHg [31.8 vs. 22.8%, P < 0.05], and non-HDL cholesterol ≥130 mg/dL [67.1 vs. 65.4%, P = 0.7]). Compared with insured persons, uninsured persons were more likely to have A1C >9% (multivariate-adjusted odds ratio 2.4 [95% CI 1.2–4.7]). Compared with those who reported four or more health care visits in the past year, those who reported no health care visits were more likely to have A1C >9% (5.5 [1.2–26.3]) and blood pressure ≥140/90 mmHg (1.9 [1.1–3.4]). CONCLUSIONS: In people with diabetes, lack of health care coverage is associated with poor glycemic control. In addition, low use of health care service is associated with poor glucose and blood pressure control.

11 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XZXuanping Zhang
Xuanping Zhang
HDHeather M Devlin
Heather M Devlin
BSBryce Smith
Bryce Smith
GIGiuseppina Imperatore
Giuseppina Imperatore
WTWilliam Thomas
William Thomas
EGEdward W Gregg
Edward W Gregg
Structured lifestyle interventions can reduce diabetes incidence and cardiovascular disease (CVD) risk among persons with impaired glucose tolerance (IGT), but it is unclear whether they should be implemented among persons without IGT. We conducted a systematic review and meta-analyses to assess the effectiveness of lifestyle interventions on CVD risk among adults without IGT or diabetes. We systematically searched MEDLINE, EMBASE, CINAHL, Web of Science, the Cochrane Library, and PsychInfo databases, from inception to May 4, 2016. We selected randomized controlled trials of lifestyle interventions, involving physical activity (PA), dietary (D), or combined strategies (PA+D) with follow-up duration ≥12 months. We excluded all studies that included individuals with IGT, confirmed by 2-hours oral glucose tolerance test (75g), but included all other studies recruiting populations with different glycemic levels. We stratified studies by baseline glycemic levels: (1) low-range group with mean fasting plasma glucose (FPG) <5.5mmol/L or glycated hemoglobin (A1C) <5.5%, and (2) high-range group with FPG ≥5.5mmol/L or A1C ≥5.5%, and synthesized data using random-effects models. Primary outcomes in this review included systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Totally 79 studies met inclusion criteria. Compared to usual care (UC), lifestyle interventions achieved significant improvements in SBP (-2.16mmHg[95%CI, -2.93, -1.39]), DBP (-1.83mmHg[-2.34, -1.31]), TC (-0.10mmol/L[-0.15, -0.05]), LDL-C (-0.09mmol/L[-0.13, -0.04]), HDL-C (0.03mmol/L[0.01, 0.04]), and TG (-0.08mmol/L[-0.14, -0.03]). Similar effects were observed among both low-and high-range study groups except for TC and TG. Similar effects also appeared in SBP and DBP categories regardless of follow-up duration. PA+D interventions had larger improvement effects on CVD risk factors than PA alone interventions. In adults without IGT or diabetes, lifestyle interventions resulted in significant improvements in SBP, DBP, TC, LDL-C, HDL-C, and TG, and might further reduce CVD risk.

1 September 2007 in Medical Care
Verified
Journal Article
Closed access
XZXuanping Zhang
Xuanping Zhang
SNSusan L. Norris
Susan L. Norris
FCFarah M. Chowdhury
Farah M. Chowdhury
EGEdward W. Gregg
Edward W. Gregg
PZPing Zhang
Ping Zhang
Health-related quality of life (HRQL) is increasingly used to measure the outcomes of interventions among people with chronic diseases. To assess the effect of interventions for adults with diabetes on HRQL, as measured by the Short Form (SF)-36 questionnaire. The systematic review was conducted using the methods of the Cochrane Collaboration. Studies reporting SF-36 scores before and after an intervention focused on adults with diabetes were obtained from searches of multiple bibliographic databases. The mean changes and standardized mean differences between pre- and post-intervention were reported as outcome measures. Pooled estimates were obtained using random effects models. We identified 33 studies examining a wide range of interventions, including diabetes education and behavioral modifications (15 studies), pharmacotherapy (11 studies), and surgery (7 studies). Interventions generally demonstrated improvement in HRQL. When all available profile scores were examined together, the ranges of mean changes in scores were as follows: surgery for treating diabetes comorbidities, 15.0 to 42.0 point improvement; surgery for treating diabetes complications, −13.0 to 37.9; pharmacotherapy using insulin to optimize glycemic control, −4.6 to 27.6; pharmacotherapy for treating comorbidities, 3.8 to 33.2; pharmacotherapy for treating complications, −2.6 to 14.6. Pooled effects from 5 randomized controlled trials of educational interventions demonstrated significantly improved physical function [3.4 (95% CI, 0.1–6.6)] and mental health [4.2 (95% CI, 1.8–6.6)], and a decrease in bodily pain [3.6 (95% CI, 0.6–6.7)]. A variety of interventions can improve HRQL among adults with diabetes, but the magnitude of effects varied with the interventions. The mechanism of these changes needs to be further examined in the future research.

1 October 2007 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
XZXuanping Zhang
Xuanping Zhang
SNSusan L. Norris
Susan L. Norris
JSJinan Saadine
Jinan Saadine
FCFarah M. Chowdhury
Farah M. Chowdhury
THTanya Horsley
Tanya Horsley
RBRalf Buhrmann
Ralf Buhrmann